BET bromodomain proteins; myeloid-lymphoid or mixed-lineage leukemia 3 (MLL3) BriefCommunication Pages: 635 - 635
Fas ligand (TNF superfamily, member 6; FASL); VEGF-A; cyclooxygenase (COX) BriefCommunication Pages: 637 - 637
NDC80 homolog kinetochore complex component (NDC80); NIMA-related kinase 2 (NEK2) BriefCommunication Pages: 638 - 638
Proteasome subunit-β type 4 (PSMB4); serine hydroxymethyltransferase 2 mitochondrial (SHMT2) BriefCommunication Pages: 639 - 639
SET and MYND domain containing 3 (SMYD3); K-Ras (KRAS); MAP kinase kinase 1 (MAP2K1; MEK1); MAP2K2 (MEK2) BriefCommunication Pages: 641 - 641
Actin α2 smooth aorta muscle (ACTA2; α-SMA); smoothened (SMO); sonic hedgehog homolog (SHH) BriefCommunication Pages: 642 - 642
Semiconductor sequencing platform (SSP) for noninvasive diagnosis of incorrect chromosome numbers BriefCommunication Pages: 654 - 654
Recombination activating gene 2 ( RAG2 ) knockout pigs to model immunodeficiency and evaluate transplant-based therapies BriefCommunication Pages: 656 - 656
Fibrin hydrogel for controlled and sustained delivery of recombinant VEGF BriefCommunication Pages: 657 - 657
Adoptive cell therapy using mutation-specific, CD4 + T cells in epithelial cancer BriefCommunication Pages: 658 - 658
Expansion of CD19-specific chimeric antigen receptor (CAR) T memory stem cells to improve adoptive T cell therapy BriefCommunication Pages: 659 - 659
Expansion of primitive, CD34 + cord blood cells with histone deacetylase (HDAC) inhibitors BriefCommunication Pages: 660 - 660
In vitro condensation of human mesenchymal stem cells (MSCs) to aid in vivo formation of functional cartilage BriefCommunication Pages: 661 - 661